| FAS (n = 35) | Surgery set (n = 32) |
---|---|---|
RECIST | ||
 Complete response, n (%) | 3 (8.6%) | 3 (9.4%) |
 Partial response, n (%) | 22 (62.9%) | 22 (68.7%) |
 Stable disease, n (%) | 7 (20.0%) | 7 (21.9%) |
 Progressive disease, n (%) | 0 | 0 |
 Objective response rate, % (95% CI) | 71.4% (53.7% to 85.4%) | 78.1% (60.0% to 90.7%) |
 Disease control rate, % (95% CI) | 91.4% (76.9% to 98.2%) | 100% (89.1% to 100.0%) * |
Tumor regression grade, n (%) | ||
 Grade 0 | 0 | 0 |
 Grade Ia | 12 (34.3%) | 12 (37.5%) |
 Grade Ib | 4 (11.4%) | 4 (12.5%) |
 Grade II | 13 (37.1%) | 13 (40.6%) |
 Grade III | 2 (5.7%) | 2 (6.2%) |
Pathological response, n (% [95% CI]) | 11 (31.4% [16.8% to 49.3%]) | 11 (34.4% [18.6% to 53.2%]) |